Cargando…
Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing
BACKGROUND: Accumulating evidence suggests alternative splicing (AS) is a co-transcriptional splicing process not only controlled by RNA-binding splicing factors, but also mediated by epigenetic regulators, such as chromatin structure, nucleosome density, and histone modification. Aberrant AS plays...
Autores principales: | Li, Tianbao, Liu, Qi, Garza, Nick, Kornblau, Steven, Jin, Victor X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902843/ https://www.ncbi.nlm.nih.gov/pubmed/29665865 http://dx.doi.org/10.1186/s13073-018-0538-1 |
Ejemplares similares
-
In Vivo Identification of H3K9me2/H3K79me3 as an Epigenetic Barrier to Carcinogenesis
por: Piro, Maria Cristina, et al.
Publicado: (2023) -
The risk model construction of the genes regulated by H3K36me3 and H3K79me2 in breast cancer
por: Wang, Ling-Yu, et al.
Publicado: (2023) -
The TUDOR domain of SMN is an H3K79(me1) histone mark reader
por: Binda, Olivier, et al.
Publicado: (2023) -
H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma
por: Martinez, Danielle R., et al.
Publicado: (2012) -
Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia
por: Richter, William F, et al.
Publicado: (2021)